General Information of Drug Inactive Ingredient (DIG) (ID: E00443)

DIG Name
Saccharin sodium anhydrous
Synonyms
SACCHARIN SODIUM; 128-44-9; Sodium saccharin; Sodium saccharine; Sodium 3-oxo-3H-benzo[d]isothiazol-2-ide 1,1-dioxide; Saccharin, sodium; Sodium saccharinate; Saccharin sodium anhydrous; Cristallose; Crystallose; Kristallose; Willosetten; Madhurin; Sucromat; Saccharin soluble; Sodium saccharide; Soluble saccharin; Saccharine soluble; Saccharin sodium salt; Saccharin, sodium salt; Sodium o-benzosulfimide; UNII-I4807BK602; o-Benzoic Sulfimide Sodium Salt; CHEBI:32112; o-Sulfonbenzoic acid imide sodium salt; Artificial sweetening substanz gendorf 450; 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt; I4807BK602; Dagutan; Sodium 1,2 benzisothiazolin-3-one 1,1-dioxide; Saccharinnatrium; Soluble gluside; Sucra; sodium;1,1-dioxo-1,2-benzothiazol-2-id-3-one; Saccharoidum natricum; Sodium benzosulphimide; sodium 3-oxo-3H-1,2-benzisothiazol-2-ide 1,1-dioxide; Saccharine sodium salt; o-Sulfobenzimide sodium salt; Sodium o-benzosulphimide; 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt (1:1); Sodium 2-benzosulphimide; 6155-57-3; 1,2-Benzothiazol-3(2H)-one 1,1-dioxide sodium salt; Saccharin sodium, anhydrous; Sodium saccharin, anhydrous; 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, Saccharin, sodium salt; Saccharinnatrium; Soluble gluside; Sweeta; Willosetten;; CCRIS 706; Benzoic acid sulfimide, sodium; FEMA No. 2997; Sulphobenzoic imide, sodium salt; o-Sulfobenzimide sodium salt dihydrate; NSC 4867; EINECS 204-886-1; Saccharin, sodium salt (C7H5NO3S.xNa); 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt; Sodium 1,2 benzisothiazolin-3-one-1,1-dioxide; Sodium 1,2-benzisothiazolin-3-one 1,1-dioxide; Sodium 1,2-benzisothiazol-3(2H)-one, 1,1-dioxide; 1,2-Benzisothiazolin-3-one, 1,1-dioxide, sodium salt; Saccharin - sodium salt; 16766-82-8; Hermesetas original (TN); DSSTox_CID_1253; EC 204-886-1; SCHEMBL3372; DSSTox_RID_76040; DSSTox_GSID_21253; CHEMBL2219743; DTXSID5021253; 1,1-Dioxide-1,2-benzisothiazol-3(2H)-one, sodium salt; 1,2-Benzisothiazolin-3-one, 1,1-dioxide, sodium deriv.; Tox21_200515; MFCD00982148; AKOS000121310; AKOS004110724; NCGC00258069-01; AC-11597; AS-69031; CAS-128-44-9; DB-041898; B0131; FT-0631749; C12284; D08500; Q27094367; Saccharin sodium 1000 microg/mL in Acetonitrile:Water; 3-Oxo-3H-1,2-benzothiazol-2-ide 1,1-dioxide (Na+, H2O); sodium 1,1,3-trioxo-2,3-dihydro-1??,2-benzothiazol-2-ide
DIG Function
Flavoring agent
Formula
C7H4NNaO3S
Canonical SMILES
C1=CC=C2C(=C1)C(=O)[N-]S2(=O)=O.[Na+]
InChI
1S/C7H5NO3S.Na/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;/h1-4H,(H,8,9);/q;+1/p-1
InChIKey
WINXNKPZLFISPD-UHFFFAOYSA-M
Physicochemical Properties Molecular Weight 205.17 Topological Polar Surface Area 60.6
XlogP N.A. Complexity 308
Heavy Atom Count 13 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

10 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Aspirin DM672AH Acute coronary syndrome [BA41] Aspirin 81 mg tablet F01664
Atovaquone DMY4UMW Fungal infection [1F29-1F2F] Atovaquone 750mg/5ml suspension F24252
Dextromethorphan DMUDJZM Allergic rhinitis [CA08.0] Dextromethorphan 15mg/5ml Syrup F23419
Macimorelin DMQYJIR Growth hormone deficiency [5A61.3] Macimorelin 60 mg solution F23222
Nifedipine DMSVOZT Angina pectoris [BA40] Nifedipine 10 mg capsule F15242
Pimavanserin DMR7IVC Parkinson disease [8A00.0] Pimavanserin 17 mg tablet F17266
Prednisone DM2HG4X Acute asthma [CA23] Prednisone 10 mg tablet F17782
Raltegravir DMYURI6 Human immunodeficiency virus infection [1C62] Raltegravir Potassium eq 25mg base Chewable tablet F23529
Ranitidine DM0GUSX Gastric ulcer [DA60] Ranitidine Hydrochloride eq 15 mg base/mL syrup F23533
Zolpidem DMWOSKJ Insomnia [7A00-7A0Z] Zolpidem 10 mg tablet F22942
------------------
⏷ Show the Full List of 10 Approved Drug(s)